US Patent Issued to Genzyme on Sept. 15 for "Methods for treating symptoms and disorders associated with lysosomal storage diseases" (Massachusetts, New Jersey Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,160, issued on Sept. 15, was assigned to Genzyme Corp. (Cambridge, Mass.).

"Methods for treating symptoms and disorders associated with lysosomal storage diseases" was invented by Nigel Patrick Somerville Crawford (Califon, N.J.) and Tanya Zaremba Fischer (Newton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure to methods for treating or preventing particular symptoms and disorders which are associated with lysosomal storage diseases using quinuclidine compounds of formula (I), optionally in combination with enzyme replacement therapy. This includes pain, such as abdominal pain, and dermatological disorders, such as angiokerato...